维普中文期刊产品整合服务
58篇 您的检索式:作者名="Allyson"
    题名 作者 年代 出处 被引量
1Helping the Consumers and Producers of Standards,Repositories and Policies to Enable FAIR Data显示文摘Thousands of community-developed(meta)data guidelines,models,ontologies,schemas and formats have been created and implemented by several thousand data repositories and knowledge-bases,across all disciplines.These resources are necessary to meet government,funder and publisher expectations of greater transparency and access to and preservation of data related to research publications.This obligates researchers to ensure their data is FAIR,share their data using the appropriate standards,store their data in sustainable and community-adopted repositories,and to conform to funder and publisher data policies.FAIR data sharing also plays a key role in enabling researchers to evaluate,re-analyse and reproduce each other’s work.We can map the landscape of relationships between community-adopted standards and repositories,and the journal publisher and funder data policies that recommend their use.In this paper,we show how the work of the GO-FAIR FAIR Standards,Repositories and Policies(StRePo)Implementation Network serves as a central integration and cross-fertilisation point for the reuse of FAIR standards,repositories and data policies in general.Pivotal to this effort,the FAIRsharing,an endorsed flagship resource of the Research Data Alliance that maps the landscape of relationships between community-adopted standards and repositories,and the journal publisher and funder data policies that recommend their use.Lastly,we highlight a number of activities around FAIR tools,services and educational efforts to raise awareness and encourage participation.Peter McQuilton Dominique Batista Oya Beyan Ramon Granell Simon Coles Massimiliano Izzo Allyson L.Lister Robert Pergl Philippe Rocca-Serra Ben Schaap Hugh Shanahan Milo Thurston Susanna-Assunta Sansone 2020Data Intelligence2020,2,1:5
2Clinical laboratory and imaging evidence for effectiveness of agarose-agarose macrobeads containing stem-like cells derived from a mouse renal adenocarcinoma cell population (RMBs) in treatment-resistant, advanced metastatic colorectal cancer:Evaluation of显示文摘Objective: The complexity, heterogeneity and capacity of malignant neoplastic cells and tumors for rapid change and evolution suggest that living-cell-based biological-systems approaches to cancer treatment are merited. Testing this hypothesis, the tumor marker, metabolic activity, and overall survival(OS) responses, to the use of one such system, implantable macrobeads [RENCA macrobeads(RMBs)], in phase I and IIa clinical trials in advanced,treatment-resistant metastatic colorectal cancer(m CRC) are described here.Methods: Forty-eight m CRC patients(30 females; 18 males), who had failed all available, approved treatments,underwent RMB implantation(8 RMB/kg body weight) up to 4 times in phase I and phase IIa open-label trials.Physicals, labs [tumor and inflammation markers, lactate dehydrogenase(LDH)] and positron emission tomography-computed tomography(PET-CT) imaging to measure number/volume and metabolic activity of the tumors were performed pre-and 3-month-post-implantation to evaluate safety and initial efficacy(as defined by biological responses). PET-CT maximum standard uptake value(SUVmax)(baseline and d 90; SUVmax ≥2.5), LDH,and carcinoembryonic antigen(CEA) and/or cancer antigen 19-9(CA 19-9) response(baseline, d 30 and/or d 60)were assessed and compared to OS.Results: Responses after implantation were characterized by an at least 20% decrease in CEA and/or CA 19-9 in75% of patients. Fluorodeoxyglucose(FDG)-positive lesions(phase I, 39; 2 a, 82) were detected in 37/48 evaluable patients, with 35% stable volume and stable or decreased SUV(10) plus four with necrosis; 10, increased tumor volume, SUV. LDH levels remained stable and low in Responders(R)(d 0–60, 290.4–333.9), but increased steadily in Non-responders(NR)(d 0–60, 382.8–1,278.5)(d 60, P=0.050). Responders to RMBs, indicated by the changes in the above markers, correlated with OS(R mean OS=10.76 months; NR mean OS=4.9 months; P=0.0006).Conclusions: The correlations of the tumor marker, tumor volume and SUV changes on PET-CT, and LDH levels themselves, and with OS, support the concept of a biological response to RMB implantation and the validity of the biological-systems approach to m CRC. A phase III clinical trial is planned.Barry H.Smith Lawrence S.Gazda Thomas J.Fahey Angelica Nazarian Melissa A.Laramore Prithy Martis Zoe P.Andrada Joanne Thomas Tapan Parikh Sudipta Sureshbabu Nathaniel Berman Allyson J.Ocean Richard D.Hall David J.Wolf 2018Chinese Journal of Cancer Research2018,30,1:2
3PFI is bad for your health 显示文摘ALLYSON P 2000Journal of Public Finance2000,,2:1
4Dopamine D2 Receptor Antagonism Suppresses Tau Aggregation and Neurotoxicity 显示文摘Allyson V McCormick 2013Biolpsychiatry2013,28,73:1
5Synthesis and evalu- ation of heparin immobilized 'side-on' to polystyrene micro- spheres coated with end-group activated polyethylene oxide 显示文摘PRANAV J KARL F S ALLYSON F 2010International Journal of Biological Macromolecules2010,47,:1
6Ethanol via biomass-generated syngas 显示文摘Lewis R S Frankman R S Allyson T 2008International Sugar Jour- nal2008,110,1311:1
7Biomechanical evaluation of surgical constructs for stabilization of cervical teardrop fractures显示文摘Allyson Ianuzzi Isidoro Zambrano Jigar Tataria Azeema Ameerally Marc Agulnick Jesse S. Little Goodwin Mark Stephen Partap S. Khalsa 2006The Spine Journal2006,,5:1
8Best practices for elderly hip fracture patients显示文摘Lauren A. Beaupre C. Allyson Jones L. Duncan Saunders D. William C. Johnston Jeanette Buckingham Sumit R. Majumdar 2005Journal of General Internal Medicine2005,,:1
9Correction of the Mutation Responsible for Sickle Cell Anemia by an RNA DNAOligonucleotide显示文摘 Kyonggeun Yoon Yufei Xiang 1996Science1996,273,:1
10Spinal cord injury and neural repair:focus on neuroregenerative approaches for spinal cord injury显示文摘Drug C Baptiste Allyson Tighe Michael G Fehlings 0,,05:1
11Assessing surveillance using sensitivity, specificity and timeliness 显示文摘Ken PK Allyson MA 2006Stat Methods Med Res2006,15,:1
12Ni-olivine Catalysts Prepared by Thermal Impregnation:Structure,Steam Reforming Activity,and Stability显示文摘Kuhn J N Zhao Z K Allyson S N 0,,:1
13Cytomegaloviral enterocolitis显示文摘Dr. Howard S. Kaufman M.D. Allyson C. Kahn M.S. Christine Iacobuzio-Donahue M.D. Ph.D. Mark A. Talamini M.D. Keith D. Lillemoe M.D. Stanley R. Hamilton M.D 1999Diseases of the Colon & Rectum1999,,1:1
14SJES14110700184569显示文摘Di?go P. Bezerra Francisco W.M. da Silva Pedro A.S. de Moura Allyson G.S. Sousa Rodrigo S. Vieira Enrique Rodriguez-Castellon Diana C.S. Azevedo 2014Applied Surface Science2014,,:1
15Characterization and surface treatment effects on topography of a glass-infiltrated alumina/zirconia-reinforced ceramic显示文摘Alvaro Della Bona Tiago A. Donassollo Flávio F. Demarco Allyson A. Barrett John J. Mecholsky 2006Dental Materials2006,,6:1
16Absent voices compromise the effectiveness of nursing home regulation:A critique of regulatory reform in the UK nursing home industry显示文摘Susan H Kerrison M Allyson M 0,,06:1
17Cyanoacrylate as a microbial sealant: Examining the evidence显示文摘Allyson Lipp Cheryl Phillips Paul Harris 2011The Journal of Perioperative Practice2011,21,1:1
18The association between chronic disease and physical disability among female Medicaid beneficiaries 18–64 years of age显示文摘Amal J. Khoury Allyson Hall Elena Andresen Jianyi Zhang Rachel Ward Chad Jarjoura 2012Disability and Health Journal2012,,:1
19Chronic disease self-management for individuals with stroke, multiple sclerosis and spinal cord injury显示文摘Robert C. Hirsche Beverly Williams Allyson Jones Patricia Manns 20112011 (13-1)2011,,13:1
20Influence of tab and disk design on shade matching of dental porcelain 显示文摘Allyson AB Nicholoas JG Denneth JA 2002J Prosthet Dent2002,88,6:1
返回顶部 每页显示:
共3页 首页 上一页 第1页 下一页 末页 /3 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费